Company: WELNF
Filing Date: 2025-10-31
Form Type: PRE 14A
Source: 0001104659-25-104954
Chunk: 45

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-10-31
Form: PRE 14A
Chunk 45
---
 shareholders in connection with such separate Business Combination Meeting, and the related right of the Company shareholders to redeem in connection with the Business Combination (which is a separate right to redeem in addition to the right to redeem in connection with the M&A Amendment Proposals), is the subject of a separate proxy statement/prospectus. If you want to ensure your Public Shares are redeemed in the event the M&A Amendments are approved at the Meeting, you should elect to “redeem” your Public Shares in connection with the Meeting.

<div align='center'>29

THE MEETING</div>

Date, Time and Place of the Meeting

The enclosed proxy is solicited
by the Board in connection with the extraordinary general meeting in lieu of an annual general meeting to be held on December 12,
2025 at 10:00 a.m. Eastern Time for the purposes set forth in the accompanying Notice of Meeting, at the offices of Ellenoff Grossman &
Schole LLP at 1345 Avenue of the Americas, 11 Floor, New York, New York 10105, or at such other time, on such other date
and at such other place to which the meeting may be adjourned.

Purpose of the Meeting

At the Meeting, you will be asked to
consider and vote upon the following matters:

(i) Proposal 1 — A
proposal to amend by special resolution (the “Extension Amendment”) the Company’s amended and restated memorandum
and articles of association as amended prior to the date hereof (the “M&A”) in the form set forth in
to the accompanying proxy statement to extend the date by which the Company would be required to consummate a business combination (the
“Extension”) from December 15, 2025 (the “Termination Date”) to March 16, 2026 (or such
earlier date as determined by the Company’s board of directors in its sole discretion) (the “Extended Date”)
(such period, the “Extension Period” and such proposal, the “Extension Amendment Proposal”);

(ii) Proposal 2 — A
proposal to amend by special resolution (the “Liquidation Amendment”, and together with the Extension Amendment, the
“M&A Amendments”) the M&A in the form set forth in Annex A to the accompanying proxy statement to permit our
Board, in its sole discretion, to elect to wind up our operations on, or on an earlier date than March 16, 2026 (including prior
to December 15,